EE492 Cost-Effectiveness of Dabigatran for Thromboembolic Events Prevention in Atrial Fibrillation Patients
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.735
https://www.valueinhealthjournal.com/article/S1098-3015(22)02939-4/fulltext
Section Title :
Section Order :
10275
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02939-4&doi=10.1016/j.jval.2022.09.735